Last Updated: November 9, 2026

Details for New Drug Application (NDA): 019879

NDA 019879 describes ORNIDYL, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the ORNIDYL profile page.

The generic ingredient in ORNIDYL is eflornithine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.

Summary for 019879

Tradename:	ORNIDYL
Applicant:	Sanofi Aventis Us
Ingredient:	eflornithine hydrochloride
Patents:	0

Medical Subject Heading (MeSH) Categories for 019879

Antineoplastic Agents
Ornithine Decarboxylase Inhibitors
Trypanocidal Agents

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	200MG/ML
Approval Date:	Nov 28, 1990	TE:		RLD:	No

Expired US Patents for NDA 019879

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	ORNIDYL	eflornithine hydrochloride	INJECTABLE;INJECTION	019879-002	Nov 28, 1990	⤷ Start Trial	⤷ Start Trial
Sanofi Aventis Us	ORNIDYL	eflornithine hydrochloride	INJECTABLE;INJECTION	019879-002	Nov 28, 1990	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.